Johnson & Johnson (JNJ)
(Delayed Data from NYSE)
$164.16 USD
-0.66 (-0.40%)
Updated Sep 20, 2024 04:00 PM ET
After-Market: $163.98 -0.18 (-0.11%) 7:58 PM ET
4-Sell of 5 4
C Value F Growth D Momentum D VGM
Income Statements
Fiscal Year end for Johnson & Johnson falls in the month of December .
All items in Millions except EPS data.
12/31/23 | 12/31/22 | 12/31/21 | 12/31/20 | 12/31/19 | |
---|---|---|---|---|---|
Sales | 85,159 | 94,943 | 93,775 | 82,584 | 82,059 |
Cost Of Goods | 26,553 | 31,089 | 29,855 | 28,427 | 27,556 |
Gross Profit | 58,606 | 63,854 | 63,920 | 54,157 | 54,503 |
Selling & Adminstrative & Depr. & Amort Expenses | 45,294 | 42,833 | 41,067 | 37,681 | 37,571 |
Income After Depreciation & Amortization | 13,312 | 21,021 | 22,853 | 16,476 | 16,932 |
Non-Operating Income | 0 | 0 | 0 | 0 | 0 |
Interest Expense | 772 | 276 | 183 | 201 | 318 |
Pretax Income | 15,062 | 21,725 | 22,776 | 16,497 | 17,328 |
Income Taxes | 1,736 | 3,784 | 1,898 | 1,783 | 2,209 |
Minority Interest | 0 | 0 | 0 | 0 | 0 |
Investment Gains/Losses | 0 | 0 | 0 | 0 | 0 |
Other Income/Charges | 0 | 0 | 0 | 0 | 0 |
Income From Cont. Operations | 13,326 | 17,941 | 20,878 | 14,714 | 15,119 |
Extras & Discontinued Operations | 21,827 | 0 | 0 | 0 | 0 |
Net Income (GAAP) | 35,153 | 17,941 | 20,878 | 14,714 | 15,119 |
Depreciation Footnote | 12/31/23 | 12/31/22 | 12/31/21 | 12/31/20 | 12/31/19 |
---|---|---|---|---|---|
Income Before Depreciation & Amortization | 20,798 | 27,991 | 30,243 | 23,707 | 23,941 |
Depreciation & Amortization (Cash Flow) | 7,486 | 6,970 | 7,390 | 7,231 | 7,009 |
Income After Depreciation & Amortization | 13,312 | 21,021 | 22,853 | 16,476 | 16,932 |
Earnings Per Share Data | 12/31/23 | 12/31/22 | 12/31/21 | 12/31/20 | 12/31/19 |
---|---|---|---|---|---|
Average Shares | 2,560.40 | 2,663.90 | 2,674.00 | 2,670.70 | 2,684.30 |
Diluted EPS Before Non-Recurring Items | 9.92 | 10.15 | 9.80 | 8.03 | 8.68 |
Diluted Net EPS (GAAP) | 13.72 | 6.73 | 7.81 | 5.51 | 5.63 |
Fiscal Year end for Johnson & Johnson falls in the month of December .
All items in Millions except EPS data.
6/30/24 | 3/31/24 | 12/31/23 | 9/30/23 | 6/30/23 | |
---|---|---|---|---|---|
Sales | 22,447.00 | 21,383.00 | 13,532.00 | 21,351.00 | 25,530.00 |
Cost Of Goods | 6,869.00 | 6,511.00 | 3,340.00 | 6,606.00 | 8,212.00 |
Gross Profit | 15,578.00 | 14,872.00 | 10,192.00 | 14,745.00 | 17,318.00 |
SG&A, R&D, and Dept/Amort Expenses | 10,350.00 | 11,731.00 | 6,919.00 | 10,084.00 | 10,948.00 |
Income After SG&A, R&D, and Dept/Amort Expenses | 5,228.00 | 3,141.00 | 3,273.00 | 4,661.00 | 6,370.00 |
Non-Operating Income | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Interest Expense | 270.00 | 155.00 | 19.00 | 192.00 | 346.00 |
Pretax Income | 5,748.00 | 3,714.00 | 3,820.00 | 5,217.00 | 6,762.00 |
Income Taxes | 1,062.00 | 459.00 | -121.00 | 908.00 | 1,618.00 |
Minority Interest | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Investment Gains/Losses | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Other Income/Charges | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Income From Cont. Operations | 4,686.00 | 3,255.00 | 3,941.00 | 4,309.00 | 5,144.00 |
Extras & Discontinued Operations | 0.00 | 0.00 | 108.00 | 21,719.00 | 0.00 |
Net Income (GAAP) | 4,686.00 | 3,255.00 | 4,049.00 | 26,028.00 | 5,144.00 |
Earnings Per Share Data | 6/30/24 | 3/31/24 | 12/31/23 | 9/30/23 | 6/30/23 |
---|---|---|---|---|---|
Average Shares | 2,422.00 | 2,430.10 | 2,430.70 | 2,549.70 | 2,625.70 |
Diluted EPS Before Non-Recurring Items | 2.82 | 2.71 | 2.29 | 2.66 | 2.80 |
Diluted Net EPS (GAAP) | 1.93 | 1.34 | 1.58 | 10.21 | 1.96 |